Daily Oncology News

The ESMO OncologyPRO news, provided in partnership with medwireNews, ensures that you're always kept up to date with the latest developments in the field of medical oncology. You can browse articles by date or by topic.

Did you know how medwireNews writes our articles?

Filter

Date Title Topic
22 Nov 2017 Intermittent Regimen ‘Feasible’ For Adjuvant Letrozole Anti-Cancer Agents & Biologic Therapy - Breast Cancer, Early Stage
20 Nov 2017 Bevaciziumab Fails To Boost OS For Progressive Glioblastoma Anti-Cancer Agents & Biologic Therapy - Central Nervous System Malignancies
20 Nov 2017 Ipilimumab Fails To Demonstrate Clinical Activity For Advanced Cervical Cancer Cancer Immunology and Immunotherapy - Cervical Cancer
17 Nov 2017 Adjuvant Neratinib Could Reduce Distant Breast Cancer Recurrence Anti-Cancer Agents & Biologic Therapy - Breast Cancer - Breast Cancer, Early Stage
16 Nov 2017 Duloxetine May Help Relieve AI-Related Musculoskeletal Side Effects Breast Cancer, Early Stage - Complications of Treatment - Supportive Care
15 Nov 2017 Early And Severe Symptoms Predict Prophylactic Anastrozole Adherence Anti-Cancer Agents & Biologic Therapy - Cancer Aetiology, Epidemiology, Prevention - Complications of Treatment
14 Nov 2017 KEYNOTE-024 Pembrolizumab Benefits Include HRQoL Outcomes Cancer Immunology and Immunotherapy - Non-Small-Cell Lung Cancer, Metastatic
13 Nov 2017 No OS Gain When Bevacizumab Is Added To Adjuvant Chemotherapy for Early-Stage NSCLC Anti-Cancer Agents & Biologic Therapy - Non-Small-Cell Lung Cancer, Early Stage
10 Nov 2017 HPV Infection Strongest Predictor of Cervical Precancer Treatment Failure Cancer Aetiology, Epidemiology, Prevention - Cervical Cancer
09 Nov 2017 ER-Positive Breast Cancer Distant Recurrence Risk Persists Long-Term After Endocrine Therapy Breast Cancer - Breast Cancer, Early Stage
08 Nov 2017 First-Line Bosutinib ‘Provides Benefit Over Imatinib’ For Chronic Phase CML Anti-Cancer Agents & Biologic Therapy - Leukaemia
07 Nov 2017 Second-Line Olaparib-Paclitaxel Fails To Make The Advanced Gastric Cancer GOLD Standard Anti-Cancer Agents & Biologic Therapy - Gastric Cancer - Translational Research
06 Nov 2017 Gene Alterations Influence Postoperative Pancreatic Cancer Survival Translational Research - Pancreatic Cancer
03 Nov 2017 RASTEN May Rule Out High-Dose Enoxaparin For SCLC Patients Small-Cell Lung Cancer
02 Nov 2017 Single NEPA Dose NonInferior To Aprepitant-Based Regimen For CINV Prevention Supportive Care